Tradestie Institutional Equity Comparison Engine

PRME vs VTYX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTYX Overall Edge

VTYX Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Growth & Margin, Momentum & Technical while PRME counters with relative strength in Options & Structure. Fundamentally, PRME trades at N/M Forward P/E with -4824.9% operating margin (+3.5% YoY revenue) versus VTYX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRME sits in SURGE (20th %ile IV; Dealer Gamma Walls on Pro) against VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PRME N/M vs VTYX N/M Fwd P/E
Growth & Margin Winner VTYX
Op Margin -4824.9% vs 0.0% ยท YoY +3.5% vs +0.0%
Momentum & Technical Winner VTYX
1Y +27.2% vs +786.1% ยท 52W Pos 48% vs 55%
Options & Structure Winner PRME
SURGE (20th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
PRME NASDAQ
Prime Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.24
-0.82% 1D
Market Cap $705.6M
1M Return +22.05%
1Y Return +27.18%
Forward P/E N/M
Unified AI Score
52.2 / 100 HOLD
Tech 53.0 Fund 54.0 Flow 65.0 Mom 50.0
VTYX NASDAQ
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
1M Return +0.36%
1Y Return +786.08%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PRME +27.18% VTYX +786.08% Spread: +19.57 pp (VTYX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PRME TTM Op. Margin: -4824.9% VTYX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRME vs VTYX. Trailing 12-month operating profitability (PRME -4824.9% vs VTYX 0.0%) and valuation multiples (PRME N/M vs VTYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PRME (2) vs VTYX (5)
Institutional Metric PRME VTYX Criterion Row Winner
Market Capitalization Scale $705.6M $1.0B Larger Scale VTYX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +3.5% +0.0% Higher Growth PRME
Operating Margin (TTM) Profitability -4824.9% 0.0% Higher Margin VTYX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -373.3% -45.4% Higher ROE VTYX
52-Week Range Position Momentum 48% ($3โ€“$6) 55% ($1โ€“$25) Stronger Trend VTYX
Beta / 30D Volatility Risk Regime 2.44ฮฒ ยท 149% Vol 2.07ฮฒ ยท 2% Vol Lower Realized Risk VTYX
Unified Institutional Score Composite Signal 52.2 / 100 (HOLD) 50.4 / 100 (HOLD) Higher Composite PRME

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PRME vs VTYX Buy Guide
PRME SURGE
13d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live PRME Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VTYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PRME nor VTYX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.